KLF4 and neoplasm: IFITM3 expression is reduced by Krüppel-like factor 4 (KLF4), a known tumor suppressor that interacts with β-catenin and thus inhibits Wnt/β-catenin signaling in the human intestinal epithelium (70, 71).